In this study, we investigated the mechanism of action by which TTM, a novel meroterpenoid that is isolated from the leaves of Rhodomyrtus tomentosa reverses P-gp-mediated MDR in cancer cells. The gene discussed is SLITRK1; the disease is cancer.